Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020672 (
hypothermia
)
17,327
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Incorporation of locally produced signaling molecules into cell-derived vesicles may serve as an endogenous mediator delivery system. We recently reported that levels
alpha-2-macroglobulin
(
A2MG
)-containing microparticles are elevated in plasma from patients with sepsis. Herein, we investigated the immunomodulatory actions of
A2MG
containing microparticles during sepsis. Administration of
A2MG
-enriched (A2MG-E)-microparticles to mice with microbial sepsis protected against
hypothermia
, reduced bacterial titers, elevated immunoresolvent lipid mediator levels in inflammatory exudates and reduced systemic inflammation.
A2MG
-E microparticles also enhanced survival in murine sepsis, an action lost in mice transfected with siRNA for LRP1, a putative
A2MG
receptor. In vitro,
A2MG
was functionally transferred onto endothelial cell plasma membranes from microparticles, augmenting neutrophil-endothelial adhesion.
A2MG
also modulated human leukocyte responses: enhanced bacterial phagocytosis, reactive oxygen species production, cathelicidin release, prevented endotoxin induced CXCR2 downregulation and preserved neutrophil chemotaxis in the presence of LPS. A significant association was also found between elevated plasma levels of
A2MG
-containing microparticles and survival in human sepsis patients. Taken together, these results identify
A2MG
enrichment in microparticles as an important host protective mechanism in sepsis.
...
PMID:Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis. 2440 64